Invited Commentary

Proton Craniospinal Irradiation for Leptomeningeal Metastases

JAMA Oncology 10.1001/jamaoncol.2025.2869

September 04, 2025 at 11:00 AM EDT

Read the full article

Corresponding Lauren Boreta, MD, Department of Radiation Oncology, University of California, San Francisco, 505 Parnassus Ave, L-75, San Francisco, CA 94143 (lauren.boreta@ucsf.edu); and David R. Raleigh, MD, PhD, Brain Tumor Center Principal Investigator and Preclinical Therapeutics Core Director, Departments of Radiation Oncology, Neurological Surgery, and Pathology, University of California, San Francisco, 1450 Third St, HD481, San Francisco, CA 94158 (david.raleigh@ucsf.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.2869?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090425

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks